VNDAVanda Pharmaceuticals Inc.vs its industry peers
A metric-by-metric comparison of Vanda Pharmaceuticals Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VNDA본 종목 | $305M#6 | — | 1.4x#7 | 1.4x#1 | 8.7%#4 | -1066.7%#14 | -70.0%#2 | -100.1%#9 | — | — | 14.9%#8 | — |
| CYPH | $332M#1 | 4.8x#2 | 2.4x#8 | 221.6x#9 | 0.0%#5 | 107.4%#2 | -2737.8%#8 | 3.6%#2 | — | — | 895.5%#1 | — |
| CATX | $326M#2 | — | 1.0x#2 | 227.3x#10 | — | -30.1%#7 | -7919.4%#10 | -31.8%#5 | -41.0%#1 | — | -5.8%#11 | — |
| QTTB | $324M#3 | 3.5x#1 | 3.1x#10 | 6.0x#2 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | 478.2%#2 | — |
| CTNM | $306M#5 | — | 1.3x#6 | — | -100.0%#9 | -41.9%#8 | — | -25.0%#4 | — | — | 7.0%#9 | — |
| ABEO | $315M#4 | — | 2.5x#9 | 54.0x#6 | — | -211.7%#11 | -1536.9%#7 | -55.6%#7 | -121.6%#2 | — | -2.4%#10 | — |
| UPB | $291M#7 | — | 1.1x#3 | 101.9x#8 | 20.4%#3 | -128.4%#10 | -5618.8%#9 | -52.9%#6 | — | — | -66.8%#14 | — |
| FULC | $288M#8 | — | 0.9x#1 | — | -100.0%#9 | -670.0%#13 | — | -24.1%#3 | — | — | -48.4%#13 | — |
| PYXS | $280M#9 | — | 24.5x#11 | 20.2x#5 | -14.2%#6 | -3.0%#5 | -609.2%#4 | -696.0%#12 | — | — | 51.8%#6 | — |
| CUE | $268M#11 | — | 116.1x#13 | 9.8x#3 | 195.7%#2 | 34.6%#3 | -96.7%#3 | -1151.6%#13 | — | — | 67.1%#3 | — |
| TRDA | $268M#10 | — | 1.1x#5 | 10.6x#4 | -87.9%#8 | -319.0%#12 | -621.1%#5 | -61.6%#8 | — | — | 35.4%#7 | — |
| GLSI | $263M#12 | — | 84.3x#12 | — | — | -11.2%#6 | — | -621.1%#11 | — | — | 58.3%#4 | — |
| LYEL | $260M#13 | — | 1.1x#4 | 7229.0x#11 | -41.0%#7 | 20.0%#4 | -748344.4%#11 | -117.4%#10 | — | — | -14.3%#12 | — |
| CAMP | $254M#14 | — | — | 72.7x#7 | 436.5%#1 | -55.2%#9 | -1502.4%#6 | — | — | — | 56.1%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice